Natixis Idexx Laboratories Inc Transaction History

Natixis

$17.6 Billion
Q3 2024

A detailed history of Natixis transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Natixis holds 5,237 shares of IDXX stock, worth $2.22 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,237

Previous 8,206 36.18%

Holding current value

$2.22 Million

Previous $4 Million 33.85%

% of portfolio

0.02%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$455.08 - $517.19 $1.35 Million - $1.54 Million	-2,969 Reduced 36.18%	5,237 $2.64 Million
Q2 2024 Aug 13, 2024	SELL	$468.04 - $548.53 $7.53 Million - $8.83 Million	-16,093 Reduced 66.23%	8,206 $4 Million
Q1 2024 May 13, 2024	BUY	$515.08 - $576.87 $9.5 Million - $10.6 Million	18,449 Added 315.37%	24,299 $13.1 Million
Q4 2023 Feb 13, 2024	BUY	$391.37 - $557.56 $743,994 - $1.06 Million	1,901 Added 48.14%	5,850 $3.25 Million
Q3 2023 Nov 14, 2023	SELL	$432.42 - $556.67 $108,105 - $139,167	-250 Reduced 5.95%	3,949 $1.73 Million
Q2 2023 Aug 11, 2023	BUY	$450.7 - $503.61 $1.47 Million - $1.65 Million	3,269 Added 351.51%	4,199 $2.11 Million
Q1 2023 May 12, 2023	SELL	$406.01 - $514.59 $2.62 Million - $3.31 Million	-6,441 Reduced 87.38%	930 $465,000
Q4 2022 Feb 24, 2023	SELL	$324.64 - $441.27 $1.13 Million - $1.54 Million	-3,482 Reduced 32.08%	7,371 $3.01 Million
Q4 2022 Feb 13, 2023	BUY	$324.64 - $441.27 $1.24 Million - $1.69 Million	3,822 Added 54.36%	10,853 $4.43 Million
Q3 2022 Nov 14, 2022	SELL	$325.8 - $407.78 $106,862 - $133,751	-328 Reduced 4.46%	7,031 $2.29 Million
Q2 2022 Aug 12, 2022	SELL	$327.37 - $553.44 $4.17 Million - $7.05 Million	-12,746 Reduced 63.4%	7,359 $2.58 Million
Q1 2022 May 13, 2022	BUY	$466.52 - $631.01 $1.33 Million - $1.8 Million	2,851 Added 16.52%	20,105 $11 Million
Q4 2021 Feb 14, 2022	BUY	$586.54 - $666.48 $8.63 Million - $9.8 Million	14,708 Added 577.69%	17,254 $11.4 Million
Q3 2021 Nov 12, 2021	SELL	$621.9 - $705.76 $91.8 Million - $104 Million	-147,685 Reduced 98.31%	2,546 $1.58 Million
Q2 2021 Aug 13, 2021	BUY	$486.36 - $637.08 $24,318 - $31,854	50 Added 0.03%	150,231 $94.9 Million
Q1 2021 May 14, 2021	SELL	$465.18 - $551.79 $1.09 Million - $1.3 Million	-2,347 Reduced 1.54%	150,181 $73.5 Million
Q4 2020 Feb 12, 2021	SELL	$383.85 - $499.87 $7.43 Million - $9.68 Million	-19,369 Reduced 11.27%	152,528 $76.2 Million
Q3 2020 Nov 12, 2020	BUY	$334.54 - $406.31 $42.4 Million - $51.6 Million	126,880 Added 281.85%	171,897 $67.6 Million
Q2 2020 Aug 13, 2020	BUY	$230.66 - $330.16 $10 Million - $14.3 Million	43,463 Added 2796.85%	45,017 $14.9 Million
Q1 2020 May 14, 2020	BUY	$182.94 - $290.97 $284,288 - $452,167	1,554 New	1,554 $376,000
Q1 2019 May 15, 2019	SELL	$178.02 - $225.69 $2.46 Million - $3.12 Million	-13,842 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$176.18 - $248.92 $1.04 Million - $1.46 Million	-5,883 Reduced 29.83%	13,842 $2.58 Million
Q3 2018 Nov 14, 2018	BUY	$218.82 - $254.46 $4.32 Million - $5.02 Million	19,725 New	19,725 $4.93 Million
Q2 2018 Aug 14, 2018	SELL	$185.56 - $227.9 $2.62 Million - $3.22 Million	-14,144 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$157.81 - $204.73 $13.2 Million - $17.1 Million	-83,577 Reduced 85.53%	14,144 $2.71 Million
Q4 2017 Feb 14, 2018	SELL	$147.68 - $168.37 $2.67 Million - $3.05 Million	-18,111 Reduced 15.64%	97,721 $15.3 Million
Q3 2017 Nov 14, 2017	SELL	$150.32 - $166.46 $4.58 Million - $5.07 Million	-30,452 Reduced 20.82%	115,832 $18 Million
Q2 2017 Aug 14, 2017	BUY	N/A	146,284	146,284 $23.6 Million

Others Institutions Holding IDXX

# of Institutions

1,206

Shares Held

73.1M

Call Options Held

152K

Put Options Held

200K

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $35.3B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Account